Theroligo

Learn More

Our Science

Using peptides and antibodies to delivery oligonucleotide-based drugs for the treatment of arthritic and lung disease

Arthritis

Category Name

Lung disease

Category Name

Oligonucleotide-based drugs

Category Name

Peptide mediated delivery

Category Name

Antibody mediated delivery

Category Name

Phage displays

Category Name

How It Works

Our novel oligonucleotide therapeutics offer new opportunities for therapeutic intervention. They specifically target disease cells and tissues, and act inside the cells to influence and reduce harmful protein production, ultimately producing therapeutic benefits to patients. Once inside the diseased cells, the oligonucleotides selectively target diseased gene messages (RNA), inducing their degradation and preventing their translation into detrimental protein products.

Step Name

This is a paragraph. You can use this to communicate content within your page. This is a paragraph. You can use this to communicate content within your page.

Step Name

This is a paragraph. You can use this to communicate content within your page. This is a paragraph. You can use this to communicate content within your page.

Step Name

This is a paragraph. You can use this to communicate content within your page. This is a paragraph. You can use this to communicate content within your page.

Step Name

This is a paragraph. You can use this to communicate content within your page. This is a paragraph. You can use this to communicate content within your page.

Link Name